behenamide은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

behenamide은 임신 중 안전한가요?

No harmonised CLP classification nor SCCS/CIR reproductive safety assessment was found for docosanamide (behenamide, CAS 3061-75-4). ECHA registration dossier and read-across justification conclude reproductive toxicity studies are not triggered and no reproductive hazard is indicated. ([echa.europa.eu](https://echa.europa.eu/mt/registration-dossier/-/registered-dossier/10893/7/9/1?utm_source=openai))

behenamide은 모유 수유 중 안전한가요?

No data show reproductive or lactation-specific hazard or systemic developmental toxicity for docosanamide; authoritative registrant assessment did not identify reproductive concerns and there is no harmonised classification. In absence of evidence, default CIR/SCCS-level concerns are not present. ([echa.europa.eu](https://echa.europa.eu/mt/registration-dossier/-/registered-dossier/10893/7/9/1?utm_source=openai))

behenamide은 아기 피부에 안전한가요?

No evidence of infant-specific hazard was found. Docosanamide is a long-chain (C22) primary fatty‑acid amide with very high estimated lipophilicity and low water solubility (low likelihood of systemic uptake from topical use), but because infant skin has a less mature barrier and higher surface‑area‑to‑weight ratio, exposure scoring is raised by +1 for babies versus adults. No studies demonstrate placental transfer, endocrine activity, or developmental toxicity. ([pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/EINECS%20221-304-1?utm_source=openai))

VeriMom은 behenamide을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 behenamide을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 behenamide 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.